Method for determining the efficacy of an anthracycline anticancer agent
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
May 18, 2010
Issued Date -
N/A
app pub date -
Nov 13, 2007
filing date -
Nov 13, 2006
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides a method for determining susceptibility to an anthracycline anticancer agent, comprising the steps consisting of detecting the expression of activated Akt in a cancer cell or cancer tissue and determining the susceptibility of the cancer cell or cancer tissue to the anthracycline anticancer agent on the basis of the detection result. The method for determining the susceptibility to an anticancer agent can be used in objective and accurate determination of the susceptibility of a cancer cell or cancer tissue to an anthracycline anticancer agent without imposing a heavy burden on a patient.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully